All News

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study study showcased the accuracy of an algorithm in identifying pregnant patients with inherited bleeding disorders, unlocking new possibilities for precision healthcare.

A recent study reveals that relugolix combination therapy demonstrates sustained reduction in menstrual bleeding volume for women with symptomatic uterine fibroids.

A recent study reveals heightened rates of concomitant bilateral salpingo-oophorectomy during benign hysterectomy in women with disabilities, shedding light on potential disparities and urging improved physician counseling and shared decision-making strategies.

Discover how active surveillance, a growing approach in managing cervical intraepithelial neoplasia, offers a nuanced alternative to immediate interventions, showcasing promising regression rates and reduced risk of overtreatment.

The Supreme Court's upcoming decision on mifepristone, a key abortion medication, may alter access, introducing potential restrictions and impacting the landscape of abortion rights.

Jay Goldberg, MD, ob-gyn at Einstein Medical Center of Philadelphia, outlines treatment options for uterine fibroids in patients with different needs.

Toby Maurer, MD, professor at University of California, San Francisco, discusses dermatologic conditions commonly seen in pediatric patients.

Toby Maurer, MD, professor at University of California, San Francisco, discusses the clinical pearls of inflammatory vulvovaginal conditions and treatment.

A recent study looks at the impact COVID-19 had on human papillomavirus vaccination rates in New York City and Long Island.

Jay Goldberg, MD, ob-gyn at Einstein Medical Center of Philadelphia, discusses treatment paradigms which can help clinicians manage abnormal uterine bleeding in their patients.

A recent study highlights significant disparities in kidney transplant and nephrology care access for pregnant patients with end-stage kidney disease, revealing reduced survival rates and limited access to crucial care compared to non-pregnancy-related causes.

Last year’s historic RSV season left many wondering if this was going to become a recurring trend. Physicians weigh in on what they are seeing at their institutions in terms of infection rates.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A comprehensive meta-analysis scrutinizes the Mediterranean diet's impact on female reproductive health, uncovering compelling evidence that links this nutritional approach to a significant reduction in adverse pregnancy outcomes.

A recent study revealed vaginal progesterone offers no significant reduction in preterm birth risk for twin gestations, prompting reconsideration of its proposed efficacy.

Daré Bioscience's tamoxifen-based therapy, DARE-VVA1, secures FDA clearance for an investigational new drug application, offering hope for women with contraindications to estrogen therapies suffering from the underdiagnosed condition of vulvar and vaginal atrophy.

Findings from a nationwide study in Sweden revealed a reduction in pregnancy weight gain among women with a history of bariatric surgery, underscoring potential clinical implications.

Discover how the implementation of peer support initiatives, such as the successful Peer Outreach Support Team, is revolutionizing healthcare culture, reducing burnout rates, and fostering positive changes among physicians.

Discover how Mosie Baby's at-home insemination kit, the first FDA-cleared of its kind, empowers individuals facing infertility challenges with an effective, easy-to-use solution for intravaginal insemination.

New research uncovers a connection between infertility and autism spectrum disorder risk, prompting a closer look at perinatal influences and the potential impact of fertility treatments on the developmental trajectory of children.

Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.

A study reveals how personalized digital health tools, such as a Digital Personal Health Librarian, leveraging electronic health records, social data, and advanced technologies, can not only enhance wellness care and preventive health but also significantly improve the uptake of interventions like HPV vaccination.

Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.

Discoveries from a comprehensive study reveal specific plasma biomarkers that may serve as indicators of neurological well-being in individuals living with HIV, shedding light on potential links to Alzheimer's disease and emphasizing the importance of early detection for improved outcomes.

Discover the American Medical Association's comprehensive principles shaping the ethical landscape of healthcare AI, paving the way for responsible development, transparency, and equitable outcomes in patient care.

A recent study reveals gaps in reproductive health services for women with disabilities, highlighting a 69% likelihood of encountering barriers, including logistical and access challenges.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.